← Back to Team

Michael Quigley

Venture Partner

Mike joined SV as a Venture Partner in 2021 and is the Chief Scientific Officer of Dualitas and on the Scientific Advisory Board of Enara Bio, both SV-created companies. Mike has also previously served as Chief Executive Officer of Therini Bio, an SV portfolio company.

Prior to joining SV, Mike was Senior Vice President of Research Biology at Gilead Sciences, overseeing the Company’s biology teams and preclinical programmes as well as protein biotherapeutics and computational biology and bioinformatics efforts across all therapeutic areas. Prior to that, he was Vice President and Head, Tumour Microenvironment Modulation Thematic Research Center at Bristol Myers Squibb and site head of the Company’s Redwood City, California location. Earlier in his career Mike led teams in Oncology Discovery at MedImmune and Janssen.

In his spare time you can find Mike with his wife and two daughters enjoying the outdoors and cycling around the Bay Area.

Academic credentials

BS, Marine Biology, Eckerd College; PhD, Immunology, Duke University; Postdoctoral Fellowship, Dana-Farber Cancer Institute, Department of Pediatric Oncology.


Investing in Women Code Logo

We invest in talented innovators. We strongly adhere to the view that diversity, including under-represented groups, strongly adds to success. If you are an entrepreneur seeking investment and a partner who can help you to build your business, we would love to hear from you. Please get in contact with our team.